The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies – A multicenter prospective trial
2011 ◽
Vol 54
(2)
◽
pp. 219-226
◽
2014 ◽
Vol 21
◽
pp. 311
Keyword(s):
2014 ◽
Vol 29
(5)
◽
pp. 1012-1018
◽